Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients

被引：0
|
作者：
Yong Hoon Kim
Ae-Young Her
Seung-Woon Rha
Byoung Geol Choi
Se Yeon Choi
Jae Kyeong Byun
Dong Oh Kang
Won Young Jang
Woohyeun Kim
Ju Yeol Baek
Woong Gil Choi
Tae Soo Kang
Jihun Ahn
Sang-Ho Park
Sung Hun Park
Ji Yeon Hong
Ji Young Park
Min-Ho Lee
Cheol Ung Choi
Chang Gyu Park
Hong Seog Seo
机构：
[1] Kangwon National University School of Medicine,Department of Internal Medicine, Division of Cardiology
[2] Korea University Guro Hospital,Cardiovascular Center
[3] Korea University Graduate School,Department of Medicine
[4] Seoul St. Mary’s Hospital,Cardiovascular Center
[5] the Catholic University of Korea,Cardiology Department
[6] Konkuk University Chungju Hospital,Department of Internal Medicine, Cardiovascular Division
[7] Dankook University Hospital,Department of Cardiology
[8] Soonchunhyang University Gumi Hospital,Cardiology Department
[9] Soonchunhyang University Cheonan Hospital,Department of Internal Medicine, Division of Cardiology, Cardiovascular Center, Nowon Eulji Medical Center
[10] Eulji University,Department of Cardiology
[11] Soonchunhyang University College of Medicine,undefined
来源：
Journal of Diabetes & Metabolic Disorders | 2020年 / 19卷
关键词：
Angiotensin converting enzyme inhibitor; Angiotensin II type 1 receptor blocker; Calcium channel blocker; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：405 / 413
页数：8
相关论文
共 50 条
  • [31] Angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor blocker: Potential agents to reduce post-surgical scar formation in humans
    Hu, Yan-Yan
    Fang, Qing-Qing
    Wang, Xiao-Feng
    Zhao, Wan-Yi
    Zheng, Bin
    Zhang, Ding-Ding
    Tan, Wei-Qiang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 (06) : 488 - 494
  • [32] Comparison of the Effect of Combination Therapy with an Angiotensin II Receptor Blocker and Either a Low-Dose Diuretic or Calcium Channel Blocker on Cardiac Hypertrophy in Patients with Hypertension
    Okura, Takafumi
    Miyoshi, Ken-ichi
    Irita, Jun
    Enomoto, Daijiro
    Jotoku, Masanori
    Nagao, Tomoaki
    Watanabe, Kouki
    Matsuoka, Hiroshi
    Ashihara, Toshiaki
    Higaki, Jitsuo
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (08) : 563 - 569
  • [33] Effects of angiotensin converting enzyme inhibitor,angio-tensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats
    ZHANG Rui-ying
    中华医学杂志(英文版), 2006, (08) : 649 - 655
  • [34] Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease
    Toto, Robert
    Palmer, Biff F.
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (03) : 372 - 380
  • [35] Efficacy of Amlodipine/Olmesartan ± Hydrochlorothiazide in Patients Uncontrolled on Prior Calcium Channel Blocker or Angiotensin II Receptor Blocker Monotherapy
    Joel Neutel
    Ali Shojaee
    Jen-Fue Maa
    Advances in Therapy, 2012, 29 : 508 - 523
  • [36] Efficacy of Amlodipine/Olmesartan ± Hydrochlorothiazide in Patients Uncontrolled on Prior Calcium Channel Blocker or Angiotensin II Receptor Blocker Monotherapy
    Neutel, Joel
    Shojaee, Ali
    Maa, Jen-Fue
    ADVANCES IN THERAPY, 2012, 29 (06) : 508 - 523
  • [37] Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: Addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker
    Furumatsu, Yoshiyuki
    Nagasawa, Yasuyuki
    Tomida, Kodo
    Mikami, Satoshi
    Kaneko, Tetsuya
    Okada, Noriyuki
    Tsubakihara, Yoshiharu
    Imai, Enyu
    Shoji, Tatsuya
    HYPERTENSION RESEARCH, 2008, 31 (01) : 59 - 67
  • [38] Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker
    Yoshiyuki Furumatsu
    Yasuyuki Nagasawa
    Kodo Tomida
    Satoshi Mikami
    Tetsuya Kaneko
    Noriyuki Okada
    Yoshiharu Tsubakihara
    Enyu Imai
    Tatsuya Shoji
    Hypertension Research, 2008, 31 : 59 - 67
  • [39] Effect of angiotensin Ⅱ type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats
    Ik Soo Byon
    Dong Hyun Lee
    Eun Sook Jun
    Min Kyu Shin
    Sung Who Park
    Ji Eun Lee
    International Journal of Ophthalmology, 2017, 10 (06) : 896 - 901
  • [40] Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis
    Mitesh Shah
    Arsh K Jain
    Steven M Brunelli
    Steven G Coca
    Philip J Devereaux
    Matthew T James
    Jin Luo
    Amber O Molnar
    Marko Mrkobrada
    Neesh Pannu
    Chirag R Parikh
    Michael Paterson
    Salimah Shariff
    Ron Wald
    Michael Walsh
    Richard Whitlock
    Duminda N Wijeysundera
    Amit X Garg
    BMC Nephrology, 15
12345